Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -618.02% is 890% below its 5-year average of -62.46%, near the high end of its 5-year range (-4223.26%–0.00%).
99.38% below its 12-month average of -309.97%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -432.73%.
NET PROFIT MARGIN
-618.02%
NET PROFIT MARGIN AVG TTM
-309.97%
NET PROFIT MARGIN AVG 3Y
-201.68%
NET PROFIT MARGIN AVG 5Y
-62.46%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-99.38%
CURRENT VS 3Y AVG
-206.44%
CURRENT VS 5Y AVG
-889.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-176477.14%
vs the sector median at left
Rani Therapeutics Holdings, Inc.
Market Cap
$54.14M
Net Profit Margin
-618.02%
TTM Avg
-309.97%
3Y Avg
-201.68%
5Y Avg
-62.46%
Market Cap
$53.70M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$52.83M
Net Profit Margin
-69.27%
TTM Avg
-45.15%
3Y Avg
-54.32%
5Y Avg
-40.58%
Market Cap
$52.60M
Net Profit Margin
-59.97%
TTM Avg
-26.95%
3Y Avg
-5.27%
5Y Avg
-0.58%
Market Cap
$56.02M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.99M
Net Profit Margin
N/A
TTM Avg
-24.71%
3Y Avg
-12.36%
5Y Avg
-8.24%
Market Cap
$51.88M
Net Profit Margin
-5668.62%
TTM Avg
-3356.71%
3Y Avg
-1974.47%
5Y Avg
-1414.89%
Market Cap
$57.01M
Net Profit Margin
-86687.50%
TTM Avg
-43373.76%
3Y Avg
-21686.88%
5Y Avg
-14457.92%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | $54.14M | -618.02% | -309.97% | -201.68% | -62.46% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aldeyra The (ALDX)vs › | $55.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | -69.27% | -45.15% | -54.32% | -40.58% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -59.97% | -26.95% | -5.27% | -0.58% |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | -24.71% | -12.36% | -8.24% |
| ImageneBio Inc (IMA)vs › | $51.88M | -5668.62% | -3356.71% | -1974.47% | -1414.89% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | -86687.50% | -43373.76% | -21686.88% | -14457.92% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-2346.0%
Net Profit Margin
-618.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -432.73% |
| 2026-03-31 | -411.77% |
| 2025-12-31 | -705.34% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -4223.26% |
| 2024-12-31 | -870.33% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | -279.70% |
| 2021-03-31 | -740.48% |
| 2020-12-31 | -7953.81% |
| 2020-09-30 | -2669.44% |
| 2020-06-30 | -4523.33% |
| 2020-03-31 | -6445.78% |
